📰 Sosei Group News
Page 4 - Sosei Group News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sosei Group. Real-time updates on events, politics, business and more.
June 30, 2023
Sosei Group (OTCMKTS:SOLTF – Free Report) was downgraded by analysts at Citigroup from a “buy” rating to a “sell” rating in a note issued to investors on Wednesday, The Fly reports. Separately, Jefferies Financial Group downgraded Sosei Group from a “buy” rating to an “underperform” rating in a report on Tuesday. Sosei Group Trading Down […]
June 29, 2023
Sosei Group Corp. has lost over half of its market value in just three days on concern about its outlook after Pfizer Inc. said Monday it will discont...
June 27, 2023
By Kosaku Narioka Sosei Group shares were indicated sharply lower Tuesday morning after its partner Pfizer decided to terminate the development of a...
June 23, 2023
Sosei Group Co. (OTCMKTS:SOLTF – Get Rating) crossed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $20.82 and traded as high as $21.00. Sosei Group shares last traded at $21.00, with a volume of 210 shares. Sosei Group Stock Performance The stock has […]
June 23, 2023
Sosei Group Co. (OTCMKTS:SOLTF – Get Rating)’s stock price passed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $20.82 and traded as high as $21.00. Sosei Group shares last traded at $21.00, with a volume of 210 shares trading hands. Sosei Group Price […]
May 12, 2023
Tokyo, Japan and Cambridge, UK, 12 May 2023 – Sosei Group Corporation (“the Company”; TSE: 4565) provides an update on operational activities and reports...
May 12, 2023
Consolidated Financial Results for the Three Months Ended March 31, 2023 ... | May 12, 2023
May 3, 2023
/PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the first quarter ended March 31, 2023 and provided an...
March 8, 2023
08.03.2023 - Tokyo, Japan and Cambridge, UK, 8 March 2023 – Sosei Group Corporation (“the Company”; TSE: 4565), the world leader in G protein-coupled receptor (GPCR) focused structure-based drug design (SBDD) and development, is pleased to announce it has ...
February 6, 2023
/PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the fourth quarter and fiscal year ended December 31,...